Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Professor John Isaacs

Newcastle AuthorsTitleYearFull text
Dr Ken Baker
JASMINE Sim
Professor John Isaacs
Biomarkers of tolerance in immune-mediated inflammatory diseases: a new era in clinical management?2021
Professor John Isaacs
Correction to: Transcriptome-wide study of TNF-inhibitor therapy in rheumatoid arthritis reveals early signature of successful treatment (Arthritis Research & Therapy, (2021), 23, 1, (80), 10.1186/s13075-021-02451-9)2021
Professor John Isaacs
EULAR points to consider on pathophysiology and use of immunomodulatory therapies in COVID-192021
Professor John Isaacs
Immunogenicity of biologic agents in rheumatology2021
Dr Dennis Lendrem
Professor John Isaacs
Influenza vaccination and interruption of methotrexate in adult patients in the COVID-19 era: an ongoing dilemma2021
Dr Dag Aarsland
Professor John O'Brien
Dr Clive Ballard
Professor John Isaacs
Professor Alan Thomas
et al.
Mild cognitive impairment: the Manchester consensus2021
Professor John Isaacs
Dr Arthur Pratt
Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial2021
Professor John Isaacs
Transcriptome-wide study of TNF-inhibitor therapy in rheumatoid arthritis reveals early signature of successful treatment2021
Professor John Isaacs
Characterization of Creatine Kinase Levels in Tofacitinib-Treated Patients with Ulcerative Colitis: Results from Clinical Trials2020
Professor John Isaacs
Correction to: Characterization of Creatine Kinase Levels in Tofacitinib‑Treated Patients with Ulcerative Colitis: Results from Clinical Trials (Digestive Diseases and Sciences, (2020), 10.1007/s10620-020-06560-4)2020
1234567891011121314151617181920...